WHO ICTRP trial
Dose finding study of maintenance therapy with Azacitidine after allogeneic…
JPRN-UMIN000018791 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000018791 |
|---|---|
| Public title | Dose finding study of maintenance therapy with Azacitidine after allogeneic hematopoietic stem cell transplantation. |
| Scientific title | Dose finding study of maintenance therapy with Azacitidine after allogeneic hematopoietic stem cell transplantation. - Dose finding study of maintenance therapy with Azacitidine after allogeneic hematopoietic stem cell transplantation for high risk MDS. (KSGCT1501, MDS-AZA-P1) |
| Primary sponsor | Kanto Study Group for Cell Therapy |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | Myelodysplastic syndrome(MDS) |
| Interventions | Azacitidine 20 mg/m2/day, 5days Azacitidine 30 mg/m2/day, 5days Azacitidine 40 mg/m2/day, 5days Azacitidine 50 mg/m2/day, 5days |
| Registration date | Aug 25, 2015 |
| Target size | 15 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: